SCPC Applauds Bipartisan Group of Lawmakers Calling for Critical Changes to Medicare Drug Price Negotiations
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement commending Chairman Buddy Carter, Rep. Jake Auchincloss and other Members of Congress for urging HHS and CMS to examine the looming impact of Medicare drug price negotiations on America’s pharmacies.
“Implementing the current Medicare drug price negotiation program without critically needed reforms will have serious consequences on all types of pharmacies and the millions of patients they serve across the country. Many long-term care (LTC) pharmacies in particular, which provide essential and legally required services to patients in nursing homes and skilled nursing facilities, are at extreme risk given the acute impact the new drug pricing program will have on the way they operate.
“SCPC applauds the recent Congressional letter, led by House Energy and Commerce Health Subcommittee Chairman Buddy Carter and Rep. Jake Auchincloss, urging leadership at HHS and CMS to quickly address the far-reaching unintended impacts of Medicare drug price negotiations. We further commend this bipartisan group of 26 lawmakers for recognizing the need to consider the impact on all types of pharmacies, including LTC pharmacies. As the Congressional letter correctly notes, the delay in manufacturer true-up payments is of particular concern for LTC pharmacies given their heavy reliance on Medicare Part D, the large volume of MFP drugs they dispense to their unique patient population, and the fact that they do not benefit from the sale of consumer goods to supplement their revenue like retail and community pharmacies.
“We encourage the Trump Administration, including leaders at HHS and CMS, to consider the important recommendations included in this letter along with the pleas of the LTC pharmacy sector and quickly enact critical reforms prior to the implementation of the Medicare drug price negotiation program in January 2026. As clearly evidenced in a recent SCPC member survey, more than half of LTC pharmacies may be forced to close locations unless significant problems with the program are quickly addressed,” said Alan Rosenbloom, President and CEO of SCPC.
###
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.